Heiskanen, Marja A. http://orcid.org/0000-0002-3817-0043
Nevalainen, Jaakko
Pahkala, Katja
Juonala, Markus
Hutri, Nina
Kähönen, Mika
Jokinen, Eero
Laitinen, Tomi P.
Tossavainen, Päivi
Taittonen, Leena
Viikari, Jorma S. A.
Raitakari, Olli T.
Rovio, Suvi P.
Funding for this research was provided by:
Horizon 2020 (755320, 848146)
European Research Council (742927)
Tampere University Hospital Supporting Foundation
Academy of Finland (286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071, 339390, 322098, 322112)
Kela
Competitive State Research Financing of the Expert Responsibility area of Kuopio
Tampere and Turku University Hospitals (X51001)
Juho Vainion Säätiö
Paavo Nurmen Säätiö
Sydäntutkimussäätiö
Suomen Kulttuurirahasto
Sigrid Juséliuksen Säätiö
Tampereen Tuberkuloosisäätiö
Emil Aaltosen Säätiö
Yrjö Jahnssonin Säätiö
Signe ja Ane Gyllenbergin Säätiö
Jenny ja Antti Wihurin Rahasto
Diabetestutkimussäätiö
University of Turku
Article History
Received: 17 April 2024
Revised: 22 May 2024
Accepted: 23 May 2024
First Online: 2 June 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The YFS was approved by the 1st ethical committee of the Hospital District of Southwest Finland and by local ethical committees (1st Ethical Committee of the Hospital District of Southwest Finland, Regional Ethics Committee of the Expert Responsibility area of Tampere University Hospital, Helsinki University Hospital Ethical Committee of Medicine, The Research Ethics Committee of the Northern Savo Hospital District and Ethics Committee of the Northern Ostrobothnia Hospital District). The study protocol of each study phase corresponded to the proposal by the World Health Organization. The study was conducted in accordance with the Declaration of Helsinki.
: All participants gave written informed consent. At prior YFS follow-ups, informed consent of every participant under the age of 18 years was obtained from a parent and/or legal guardian.